Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : SA to Soon Administer Over 300,000 Covid-19 Vaccines a Day

07/29/2021 | 12:06pm EDT

Government is gearing up to administer over 300 000 COVID-19 vaccination inoculations a day, with an unprecedented amount of doses set to arrive in the country in the next coming days and weeks.

The delivery of the vaccines will soon see the country have enough stock for about 50 days.

As of Thursday, the country had administered over 7 million doses. Of these, 903 000 were Johnson & Johnson doses exclusively for essential public services sectors like social development, the police and military personnel. Since 17 May, 4.3 million Pfizer first doses and 1.3 million second doses have been administered.

Department of Health Deputy Director-General for the National Health Insurance, Dr Nicholas Crisp, emphasised this during a digital media webinar on how government can leverage social media in the fight against COVID-19.

The Government Communication and Information System (GCIS) and the University of Johannesburg's (UJ) Institute hosted Thursday's webinar.

He said: "This week is the least vaccines we've ever had in the system".

"We are geared to do well over 300 000 vaccinations a day. We have this little window of this week where we have not yet received the Johnson & Johnson vaccine.

This was set to begin changing from Saturday when the country begins to receive large Pfizer consignments.

"We have received some vaccines last Sunday - another 960 000 doses - but the main vaccines will really start to arrive on Saturday, Sunday, Tuesday, and the week after that," he said.

A Johnson & Johnson vaccine batch could also arrive this Friday, but this is yet to be confirmed.

Once these vaccines arrive, the country could have at least 50 days of vaccines available. This would exponentially bolster South Africa's vaccination programme and see it go "flat out".

"It's those within the groups that are over the age of 60 and 50, that we must continue to reach and our messaging must really continue to ask the young people to bring their parents and their grandparents for vaccinations," he said.

He said while some people could walk into vaccination sites and receive jabs, it was still preferred that individuals registered on the designated Electronic Vaccination Data System (EVDS) self-registration portal.

"There's a race against time, as I said, but the biggest race is to get as many of the older population as possible vaccinated as we possibly can," said Crisp.

Copyright SAnews.gov.za. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON -0.10% 164.46 Delayed Quote.4.54%
PFIZER, INC. 0.49% 44.185 Delayed Quote.20.08%
All news about JOHNSON & JOHNSON
08:58aPRO BANKRUPTCY BRIEFING : J&J Beats Injury Lawyers on Talc Bankruptcy; Judge Questions Tal..
DJ
09/21JOHNSON & JOHNSON : Unit Collaborates With Persephone Biosciences On Stool Analysis
MT
09/21Shangula Rages Against West's Vaccine Nationalism
AQ
09/21Johnson & Johnson Data Shows COVID-19 Booster Shots 94% Effective Against Moderate to S..
MT
09/21Today on Wall Street: Markets at a pivot point
09/21JOHNSON & JOHNSON : Says New Data Show Booster Shot Increases COVID-19 Protection
MT
09/21J&J : Booster dose of its COVID shot prompts strong response
AQ
09/21JOHNSON & JOHNSON : Says New Data Shows a Booster of its One-Shot Vaccine Increases COVID-..
MT
09/21JOHNSON & JOHNSON : Announces Real-World Evidence and Phase 3 Data Confirming Strong and L..
PR
09/21Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and ..
CI
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 19,1x
Yield 2021 2,53%
Capitalization 433 B 433 B -
EV / Sales 2021 4,61x
EV / Sales 2022 4,41x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 164,53 $
Average target price 185,83 $
Spread / Average Target 12,9%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.54%433 122
ROCHE HOLDING AG9.82%321 584
PFIZER, INC.20.08%246 246
NOVO NORDISK A/S52.07%234 070
ELI LILLY AND COMPANY36.32%208 668
ABBVIE INC.0.00%189 353